Finnrick, an independent testing programme, publishes 91 assays for Shanghai Baoju: 73 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 18 did not. Most recent assay 21 Jul 2026.
Shanghai Baoju listed by Finnrick as "active", has no storefront on record — Finnrick lists only a messaging or social contact. Source: Finnrick, https://www.finnrick.com/vendors/shanghai-baoju.
Finnrick-tested with poor results. Tested across 2 peptide products with 43 total samples.
Shanghai Baoju is listed as active. Finnrick Grade D. Finnrick avg score: 7.1/10 across 43 samples (2 products). Below-average quality. Exercise caution.
Shanghai Baoju holds independent lab grade D, assigned across 43 graded samples, average score 7.1/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for Shanghai Baoju, and we have not yet compiled a profile of its own website. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 28 | 24 passed, 4 failed |
| Tirzepatide | 28 | 22 passed, 6 failed |
| GHK-Cu | 11 | 11 passed, 0 failed |
| BPC-157 | 6 | 4 passed, 2 failed |
| Cagrilintide | 5 | 5 passed, 0 failed |
| Ipamorelin | 5 | 3 passed, 2 failed |
| TB-500 | 4 | 1 passed, 3 failed |
| Tesamorelin | 4 | 3 passed, 1 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | D (43 samples) |
| Average grader score | 7.1/10 |
| Vendor type | Research-use supplier |
Shanghai Baoju is listed as active and we hold 91 Finnrick assays (73 passing, 18 failing its purity threshold); an independent lab grade of D. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 91 assays for Shanghai Baoju: 73 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 18 did not. Most recent assay 21 Jul 2026.
Similar vendors: SwissChems, Bfflink, Reta-Peptide, HkRoids, Zenith Jove Peptide ZJ, Heman Peptide HM, Allen Biotechnology Co ABC, Shenzhen Loga Tech LG LOGA.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Shanghai Chinqesen Biotechnology Peptides Review, Shanghai ERP peptide Biotechnology Review, Shanghai Huahaige Plastic Peptides Review.